The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Enterovirus Vaccine-Global Market Insights and Sales Trends 2024
Synopsis
Hand, foot and mouth disease (HFMD) was first reported in New Zealand in 1957 and occurs mostly in young children, with a peak incidence at about 2 years of age. The causative agents of HFMD are picornaviruses, most often of human enterovirus species A, chiefly the Coxsackie A viruses and Enterovirus A71 (EV71). To date three vaccines against EV71 have been licensed in China, all using C4 genogroup strains. The efficacy of these three vaccines after two doses immunization ranges from 90.0% to 97.4% after one year of surveillance to 95.1% after two-year follow-up. Candidate vaccines containing B4 and B5 genogroups are in development elsewhere but have not yet reached the licensing stage. Other vaccines such as recombinant and other forms of subunit vaccines, vectored vaccines, virus-like particle vaccines are in the early stage of development. In addition, the development of vaccines against Coxsackie A16, A6 and A10 is being considered with a view to developing combination/multivalent vaccines
The global Enterovirus Vaccine market size is expected to reach US$ 482.5 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of Enterovirus Vaccine in various end use industries. The expanding demands from the Hospital, Research Institute and Others,, are propelling Enterovirus Vaccine market. Coxasckievirus A, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Coxasckievirus B segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Enterovirus Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Enterovirus Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Enterovirus Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Enterovirus Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Enterovirus Vaccine covered in this report include Sinovac Biotech, Medigen Vaccine Biologics, Shenzhen Neptunus, Sinopharm, Adimmune, Intravacc, Shanghai Zerun Biotechnology and Beijing Minhai Biotechnology, etc.
The global Enterovirus Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sinovac Biotech
Medigen Vaccine Biologics
Shenzhen Neptunus
Sinopharm
Adimmune
Intravacc
Shanghai Zerun Biotechnology
Beijing Minhai Biotechnology
Global Enterovirus Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Enterovirus Vaccine market, Segment by Type:
Coxasckievirus A
Coxasckievirus B
Human Enterovirus 71
Others
Global Enterovirus Vaccine market, by Application
Hospital
Research Institute
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Enterovirus Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Enterovirus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Hand, foot and mouth disease (HFMD) was first reported in New Zealand in 1957 and occurs mostly in young children, with a peak incidence at about 2 years of age. The causative agents of HFMD are picornaviruses, most often of human enterovirus species A, chiefly the Coxsackie A viruses and Enterovirus A71 (EV71). To date three vaccines against EV71 have been licensed in China, all using C4 genogroup strains. The efficacy of these three vaccines after two doses immunization ranges from 90.0% to 97.4% after one year of surveillance to 95.1% after two-year follow-up. Candidate vaccines containing B4 and B5 genogroups are in development elsewhere but have not yet reached the licensing stage. Other vaccines such as recombinant and other forms of subunit vaccines, vectored vaccines, virus-like particle vaccines are in the early stage of development. In addition, the development of vaccines against Coxsackie A16, A6 and A10 is being considered with a view to developing combination/multivalent vaccines
The global Enterovirus Vaccine market size is expected to reach US$ 482.5 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of Enterovirus Vaccine in various end use industries. The expanding demands from the Hospital, Research Institute and Others,, are propelling Enterovirus Vaccine market. Coxasckievirus A, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Coxasckievirus B segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Enterovirus Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Enterovirus Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Enterovirus Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Enterovirus Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Enterovirus Vaccine covered in this report include Sinovac Biotech, Medigen Vaccine Biologics, Shenzhen Neptunus, Sinopharm, Adimmune, Intravacc, Shanghai Zerun Biotechnology and Beijing Minhai Biotechnology, etc.
The global Enterovirus Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sinovac Biotech
Medigen Vaccine Biologics
Shenzhen Neptunus
Sinopharm
Adimmune
Intravacc
Shanghai Zerun Biotechnology
Beijing Minhai Biotechnology
Global Enterovirus Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Enterovirus Vaccine market, Segment by Type:
Coxasckievirus A
Coxasckievirus B
Human Enterovirus 71
Others
Global Enterovirus Vaccine market, by Application
Hospital
Research Institute
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Enterovirus Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Enterovirus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Enterovirus Vaccine Market Overview
1.1 Enterovirus Vaccine Product Overview
1.2 Enterovirus Vaccine Market Segment by Type
1.2.1 Coxasckievirus A
1.2.2 Coxasckievirus B
1.2.3 Human Enterovirus 71
1.2.4 Others
1.3 Global Enterovirus Vaccine Market Size by Type
1.3.1 Global Enterovirus Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global Enterovirus Vaccine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Enterovirus Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Enterovirus Vaccine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Enterovirus Vaccine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Enterovirus Vaccine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Enterovirus Vaccine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Enterovirus Vaccine Sales Breakdown by Type (2018-2023)
2 Global Enterovirus Vaccine Market Competition by Company
2.1 Global Top Players by Enterovirus Vaccine Sales (2018-2023)
2.2 Global Top Players by Enterovirus Vaccine Revenue (2018-2023)
2.3 Global Top Players by Enterovirus Vaccine Price (2018-2023)
2.4 Global Top Manufacturers Enterovirus Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Enterovirus Vaccine Market Competitive Situation and Trends
2.5.1 Enterovirus Vaccine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Enterovirus Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Enterovirus Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Enterovirus Vaccine Market
2.8 Key Manufacturers Enterovirus Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Enterovirus Vaccine Status and Outlook by Region
3.1 Global Enterovirus Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Enterovirus Vaccine Historic Market Size by Region
3.2.1 Global Enterovirus Vaccine Sales in Volume by Region (2018-2023)
3.2.2 Global Enterovirus Vaccine Sales in Value by Region (2018-2023)
3.2.3 Global Enterovirus Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Enterovirus Vaccine Forecasted Market Size by Region
3.3.1 Global Enterovirus Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global Enterovirus Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global Enterovirus Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Enterovirus Vaccine by Application
4.1 Enterovirus Vaccine Market Segment by Application
4.1.1 Hospital
4.1.2 Research Institute
4.1.3 Others
4.2 Global Enterovirus Vaccine Market Size by Application
4.2.1 Global Enterovirus Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global Enterovirus Vaccine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Enterovirus Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Enterovirus Vaccine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Enterovirus Vaccine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Enterovirus Vaccine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Enterovirus Vaccine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Enterovirus Vaccine Sales Breakdown by Application (2018-2023)
5 North America Enterovirus Vaccine by Country
5.1 North America Enterovirus Vaccine Historic Market Size by Country
5.1.1 North America Enterovirus Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Enterovirus Vaccine Sales in Volume by Country (2018-2023)
5.1.3 North America Enterovirus Vaccine Sales in Value by Country (2018-2023)
5.2 North America Enterovirus Vaccine Forecasted Market Size by Country
5.2.1 North America Enterovirus Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America Enterovirus Vaccine Sales in Value by Country (2024-2029)
6 Europe Enterovirus Vaccine by Country
6.1 Europe Enterovirus Vaccine Historic Market Size by Country
6.1.1 Europe Enterovirus Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Enterovirus Vaccine Sales in Volume by Country (2018-2023)
6.1.3 Europe Enterovirus Vaccine Sales in Value by Country (2018-2023)
6.2 Europe Enterovirus Vaccine Forecasted Market Size by Country
6.2.1 Europe Enterovirus Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe Enterovirus Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Enterovirus Vaccine by Region
7.1 Asia-Pacific Enterovirus Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Enterovirus Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Enterovirus Vaccine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Enterovirus Vaccine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Enterovirus Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Enterovirus Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Enterovirus Vaccine Sales in Value by Region (2024-2029)
8 Latin America Enterovirus Vaccine by Country
8.1 Latin America Enterovirus Vaccine Historic Market Size by Country
8.1.1 Latin America Enterovirus Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Enterovirus Vaccine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Enterovirus Vaccine Sales in Value by Country (2018-2023)
8.2 Latin America Enterovirus Vaccine Forecasted Market Size by Country
8.2.1 Latin America Enterovirus Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Enterovirus Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Enterovirus Vaccine by Country
9.1 Middle East and Africa Enterovirus Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Enterovirus Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Enterovirus Vaccine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Enterovirus Vaccine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Enterovirus Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Enterovirus Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Enterovirus Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sinovac Biotech
10.1.1 Sinovac Biotech Company Information
10.1.2 Sinovac Biotech Introduction and Business Overview
10.1.3 Sinovac Biotech Enterovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Sinovac Biotech Enterovirus Vaccine Products Offered
10.1.5 Sinovac Biotech Recent Development
10.2 Medigen Vaccine Biologics
10.2.1 Medigen Vaccine Biologics Company Information
10.2.2 Medigen Vaccine Biologics Introduction and Business Overview
10.2.3 Medigen Vaccine Biologics Enterovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Medigen Vaccine Biologics Enterovirus Vaccine Products Offered
10.2.5 Medigen Vaccine Biologics Recent Development
10.3 Shenzhen Neptunus
10.3.1 Shenzhen Neptunus Company Information
10.3.2 Shenzhen Neptunus Introduction and Business Overview
10.3.3 Shenzhen Neptunus Enterovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Shenzhen Neptunus Enterovirus Vaccine Products Offered
10.3.5 Shenzhen Neptunus Recent Development
10.4 Sinopharm
10.4.1 Sinopharm Company Information
10.4.2 Sinopharm Introduction and Business Overview
10.4.3 Sinopharm Enterovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Sinopharm Enterovirus Vaccine Products Offered
10.4.5 Sinopharm Recent Development
10.5 Adimmune
10.5.1 Adimmune Company Information
10.5.2 Adimmune Introduction and Business Overview
10.5.3 Adimmune Enterovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Adimmune Enterovirus Vaccine Products Offered
10.5.5 Adimmune Recent Development
10.6 Intravacc
10.6.1 Intravacc Company Information
10.6.2 Intravacc Introduction and Business Overview
10.6.3 Intravacc Enterovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Intravacc Enterovirus Vaccine Products Offered
10.6.5 Intravacc Recent Development
10.7 Shanghai Zerun Biotechnology
10.7.1 Shanghai Zerun Biotechnology Company Information
10.7.2 Shanghai Zerun Biotechnology Introduction and Business Overview
10.7.3 Shanghai Zerun Biotechnology Enterovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Shanghai Zerun Biotechnology Enterovirus Vaccine Products Offered
10.7.5 Shanghai Zerun Biotechnology Recent Development
10.8 Beijing Minhai Biotechnology
10.8.1 Beijing Minhai Biotechnology Company Information
10.8.2 Beijing Minhai Biotechnology Introduction and Business Overview
10.8.3 Beijing Minhai Biotechnology Enterovirus Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Beijing Minhai Biotechnology Enterovirus Vaccine Products Offered
10.8.5 Beijing Minhai Biotechnology Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Enterovirus Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Enterovirus Vaccine Industrial Chain Analysis
11.4 Enterovirus Vaccine Market Dynamics
11.4.1 Enterovirus Vaccine Industry Trends
11.4.2 Enterovirus Vaccine Market Drivers
11.4.3 Enterovirus Vaccine Market Challenges
11.4.4 Enterovirus Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Enterovirus Vaccine Distributors
12.3 Enterovirus Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
